These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9029168)

  • 1. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells.
    Fujita M; Takahashi R; Kitada K; Watanabe R; Kitazawa S; Ashoori F; Liang P; Saya H; Serikawa T; Maeda S
    Cancer Lett; 1997 Jan; 112(1):47-55. PubMed ID: 9029168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of alternative splicing of the rat erythropoietin receptor gene in normal and erythroleukemia cells.
    Fujita M; Takahashi R; Liang P; Saya H; Ashoori F; Tachi M; Kitazawa S; Maeda S
    Leukemia; 1997 Apr; 11 Suppl 3():444-5. PubMed ID: 9209419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a truncated erythropoietin receptor for erythroid differentiation.
    Nakamura Y; Tokumoto Y; Nakauchi H
    Biochem Biophys Res Commun; 1996 Jan; 218(1):205-9. PubMed ID: 8573132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors.
    Fichelson S; Chrétien S; Rokicka-Piotrowicz M; Bouhanik S; Gisselbrecht S; Mayeux P; Lacombe C
    Biochem Biophys Res Commun; 1999 Mar; 256(3):685-91. PubMed ID: 10080960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-1 and erythropoietin receptor genes are highly expressed in erythroleukemia.
    Komatsu N; Kirito K; Izumi T; Eguchi M; Miura Y
    Exp Hematol; 1998 Nov; 26(12):1148-54. PubMed ID: 9808054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line.
    Ward JC; Harris KW; Penny LA; Forget BG; Kitamura T; Winkelmann JC
    Exp Hematol; 1992 Mar; 20(3):371-3. PubMed ID: 1314735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel alternative splicing mode of the erythropoietin receptor gene in rats].
    Lu Q; Ye Q; Wen L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Nov; 20(11):580-2. PubMed ID: 11721375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells.
    Ge Y; Li ZH; Marshall MS; Broxmeyer HE; Lu L
    Blood Cells Mol Dis; 1998 Jun; 24(2):124-36; discussion 137. PubMed ID: 9628849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiation and maturation of erythroblasts].
    Nakamura Y
    Rinsho Byori; 1998 May; 46(5):435-40. PubMed ID: 9627494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
    Subramanian A; Hegde S; Correll PH; Paulson RF
    Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice containing the human erythropoietin receptor gene exhibit correct hematopoietic and neural expression.
    Liu C; Yu K; Shen K; Liu Z; Noguchi CT
    Proc Assoc Am Physicians; 1996 Nov; 108(6):449-54. PubMed ID: 8956368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
    Elliott S; Busse L; McCaffery I; Rossi J; Sinclair A; Spahr C; Swift S; Begley CG
    J Immunol Methods; 2010 Jan; 352(1-2):126-39. PubMed ID: 19887071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of expression of the human erythropoietin receptor gene.
    Winter SS; Howard T; Ware RE
    Blood Cells Mol Dis; 1996; 22(3):214-24; discussion 224a. PubMed ID: 9075572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
    Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
    Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.